Argeris M. Karabelas
Chairman
Pharmaceuticals
Polyphor
Switzerland
Biography
Argeris (“Jerry”) M. Karabelas, Ph.D., is a Partner at Care Capital, LLC, a life sciences venture firm with $500MM under management. Previous to this position, Dr. Karabelas founded the Novartis BioVenture Fund. He was also the CEO of Worldwide Pharmaceuticals, and head of all healthcare businesses and a member of the Executive Committee at Novartis AG. Prior to that he held a number of senior executive positions at SmithKline Beecham. He was also a Professor of Pharmacokinetics. Dr. Karabelas has founded several companies: CytoTherapeutics, Inc., Vanda Pharmaceuticals Inc., Cyrenaic, and Somnus. He is currently a member of the Board of Valeant Pharmaceuticals, Braeburn Pharmaceuticals, and Regenxbio Pharmaceuticals. He is former Chairman of Human Genome Sciences, Vanda Pharmaceuticals Inc., Renovo, NitroMed, Inc., and SkyePharma plc. Dr. Karabelas holds a Ph.D. in Pharmaceutical Sciences and Pharmacokinetics from the Massachusetts College of Pharmacy and a Bachelor of Sciences in Biochemistry from the University of New Hampshire.
Research Interest
Business
